One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editor's Choice – John Ingram May 2024Â
doi : 10.1093/bjd/ljae115
British Journal of Dermatology, Volume 190, Issue 5, May 2024, Pages i–ii
Inclusive and equitable language for skin colour in the British Journal of Dermatology: acknowledging our past and laying the foundations to move forwardÂ
Linda Oyesiku, Ncoza Dlova, Shehnaz Ahmed, David R Owen, John R Ingram, Esther Freeman, Nina G JablonskiÂ
doi : 10.1093/bjd/ljae064
Development of a novel treatment for pemphigus and confirmation of its efficacy: a randomized controlled trial of protein A immunoadsorption therapyÂ
Takashi Hashimoto, Jun Yamagami
doi : 10.1093/bjd/ljae008
New insights in the complex relationship between psoriasis and vitamin D…and, not to forget, obesity!
Charlotte Näslund-Koch, Lone Skov
doi : 10.1093/bjd/ljad506
Biologic survival: a novel approach for drug efficacy estimation in psoriasis
Qinmengge Li, Lam C Tsoi
doi : 10.1093/bjd/ljae007
How can we better address patients’ needs in topical psoriasis treatment?
Junfen Zhang, Marie L A Schuttelaar
doi : 10.1093/bjd/ljae046
A pledge for a better care and consideration of patients with vitiligo
Thierry Passeron
doi : 10.1093/bjd/ljae083
Improving cancer stem cells killing in malignant melanoma
Daniele Bergamaschi
doi : 10.1093/bjd/ljae035
Topical gene editing therapeutics using lipid nanoparticles: ‘gene creams’ for genetic skin diseases?Â
Ina Guri-Lamce, Yara AlRokh, Youngah Kim, Ruhina Maeshima, Carina Graham, Stephen L Hart, John A McGrath, Joanna Jacków-MalinowskaÂ
doi : 10.1093/bjd/ljad528
The sialic acid–Siglec immune checkpoint: an opportunity to enhance immune responses and therapy effectiveness in melanomaÂ
Magali Coccimiglio, Fabrizio Chiodo, Yvette van KooykÂ
doi : 10.1093/bjd/ljad517
Neonatal epidermolysis bullosa: a clinical practice guidelineÂ
Rebecca Saad, José Duipmans, Natalie Yerlett, Katie Plevey, Catherine McCuaig, William Woolfe, K Steinau, Jennifer Phillips, Nina Azzopardi, Kerry Thompson, Anna Carolina Ferreira da Rocha, Maurico Torres-Pradilla, Hagen Ott, Declan Patton, Zena Moore, Paul Murphy, Kattya Mayre-Chilton
doi : 10.1093/bjd/ljae006
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trialÂ
Nina van Beek, Rüdiger Eming, Alexander Reuss, Detlef Zillikens, Miklós Sárdy, Claudia Günther, Dimitra Kiritsi, Sandrine Benoit, Stefan Beissert, Regine Gläser, Harald Gollnick, Orsolya N Horváth, Christiane Pfeiffer, Martin Röcken, Franziska Schauer, Stephan Schreml, Kerstin Steinbrink, Alexander Zink, Carmen Schade-Brittinger, Michael Hertl, Enno Schmidt
doi : 10.1093/bjd/ljad489
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trialsÂ
Mark Lebwohl, Richard B Warren, Howard Sofen, Shinichi Imafuku, Carle Paul, Jacek C Szepietowski, Lynda Spelman, Thierry Passeron, Eleni Vritzali, Andrew Napoli, Renata M Kisa, Alex Buck, Subhashis Banerjee, Diamant Thaçi, Andrew Blauvelt
doi : 10.1093/bjd/ljae014
The association between serum 25-hydroxyvitamin D levels and psoriasis in a large population-based cohort: a cross-sectional analysis of The Tromsø Study 2015–16Â
Marita Jenssen, Anne-Sofie Furberg, Rolf Jorde, Tom Wilsgaard, Kjersti Danielsen
doi : 10.1093/bjd/ljad472
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, Richard B Warren, Nick Dand, Jonathan N Barker, Catherine H Smith, Christopher E M Grif�ths, the BADBIR and BSTOP study group
doi : 10.1093/bjd/ljad481
Goals and benefits in topical treatment for psoriasis: development and pilot validation of a patient-reported outcomes tool, the Patient Benefit Index for Topical Treatment (PBI-TOP)
Christine Blome, Lennart Hülswitt, Anna Meineke, Matthias Augustin, Frenz Ohm, Judith Rusch, Toni Maria Janke
doi : 10.1093/bjd/ljad484
Stigma in vitiligo: associated factors and severity strata of the Patient Unique Stigmatization Holistic tool in Dermatology (PUSH-D) score
Ali Fakih, Rim Tannous, Mohamed Lajnef, Julien Seneschal, Nicolas Andreu, Viet-Thi Tran, Khaled Ezzedine
doi : 10.1093/bjd/ljae020
Further refinement of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure using classical test theory and item response theoryÂ
Rachael Pattinson, Nirohshah Trialonis-Suthakharan, Tim Pickles, Jennifer Austin, Allison FitzGerald, Matthias Augustin, Christine BundyÂ
doi : 10.1093/bjd/ljad487
Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing
Abdullahi B Mukhtar, Huw J Morgan, Alex Gibbs, Gemma E Davies, Charlotte Lovatt, Girish K Patel
doi : 10.1093/bjd/ljad502
Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot studyÂ
Jesús Peña-MartÃn, MarÃa Belén GarcÃa-Ortega, José Luis Palacios-Ferrer, Caridad DÃaz, MarÃa Ã�ngel GarcÃa, Houria Boulaiz, Javier Valdivia, José Miguel Jurado, Francisco M Almazan-Fernandez, Salvador Arias Santiago, Francisca Vicente, Coral del Val, José Pérez del Palacio, Juan Antonio Marchal
doi : 10.1093/bjd/ljae013
Trends in occupational and work-related contact dermatitis attributed to nickel, chromium and cobalt in the UK: findings from The Health and Occupation Research network 1996–2019Â
Ireny Y K Iskandar, David J Gawkrodger, Matthew Gittins, Laura Byrne, Melanie Carder, Martie van Tongeren
doi : 10.1093/bjd/ljad488
Atopic dermatitis and autism: tactile hypersensitivity impeding topical therapy use
Li Jie Helena Yoo, Nicholas Stefanovic, Richard E Watchorn
doi : 10.1093/bjd/ljae005
Adverse healthcare experiences are correlated with increased time to diagnosis in women with vulvar inflammatory dermatoses: a retrospective cohort survey
Sydney Rivera, Kylie Dehner, Anna Flood, Chandler Dykstra, Melissa M Mauskar, Andrea L DeMaria
doi : 10.1093/bjd/ljae003
Detection of α-papillomaviruses in extragenital cutaneous squamous cell carcinomas
Morgane Weiss, Valentine M Ferré, Lydia Deschamps, Diane Evrard, Clémentine Gonthier, Charlotte Charpentier, Florence Brunet-Possenti
doi : 10.1093/bjd/ljae047
Global burden of vaccine-associated alopecia, 1979–2023: a comprehensive analysis of the international pharmacovigilance database
Seoyeon Kyung, Selin Woo, Minji Kim, Hayeon Lee, Jiseung Kang, Masoud Rahmati, Dong Keon Yon
doi : 10.1093/bjd/ljae055
A guide to improving the design and analysis of observational studies on the long-term safety of topical corticosteroids
Aaron M Drucker, Peter C Austin, Jane Harvey, Stephanie J Lax, Mina Tadrous, Kim S Thomas
doi : 10.1093/bjd/ljae065
Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study
Hans Christian Ring, Jonathan Thorsen, Brian Kirby, John R Ingram, Nana Aviaaja Lippert Rosenø, Nikolaj Holgersen, Valdemar W Nielsen, David Nikolai Thein Aagaard, Julia-Tatjana Maul, Jashin J Wu, Jacob P Thyssen, Alexander Egeberg, Simon F Thomsen
doi : 10.1093/bjd/ljae042
Effectiveness and safety of major systemic treatments in classic and endemic Kaposi sarcoma: a multicentre retrospective study of 110 patients
Chloé Grolleau, Anouk Walter-Petrich, Nicolas Dupin, Johan Chanal, Ouidad Zehou, Claire Montlahuc, Barouyr Baroudjian, Laetitia Da Meda, Matthieu Resche-Rigon, Laurence Le Cleach, Céleste Lebbé
doi : 10.1093/bjd/ljae032
Ichthyosis: multinational European study on patient characteristics, involved body sites and impact on quality of lifeÂ
May El Hachem, Rita De Marco, José MarÃa Soria de Francisco, Anne Audouze, Mandy Aldwin-Easton, Charbel Skayem, Charles Taieb, Markéta Saint Aroman, Hélène Ghienne, Catherine Baissac, Juliette Mazereeuw, Christine Bodemer
doi : 10.1093/bjd/ljae082
Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study
Samar B Hasan, Janine Bates, Rebecca Cannings-John, Fiona Collier, Judith Evans, Angela Gibbons, Ceri Harris, Laura Howells, Kerenza Hood, Rachel Howes, Paul Leighton, Muhammad Riaz, Jeremy Rodrigues, Helen Stanton, Kim S Thomas, Emma Thomas-Jones, John R Ingram
doi : 10.1093/bjd/ljae057
Correction to: How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approachÂ
doi : 10.1093/bjd/ljae060
Correction to: Malignancy risk in patients with atopic dermatitis: a population-based cohort studyÂ
doi : 10.1093/bjd/ljae093
Practical guide for epidermolysis bullosa management in the first 4 weeks of lifeÂ
doi : 10.1093/bjd/ljae118
Effectiveness and safety of immunoadsorption in the treatment of pemphigus vulgaris and pemphigus foliaceusÂ
doi : 10.1093/bjd/ljae119
The association between vitamin D levels and psoriasis in people aged 40–79 yearsÂ
doi : 10.1093/bjd/ljae120
Predictors of response to treatment with biologics in people with moderate-to-severe psoriasisÂ
doi : 10.1093/bjd/ljae121
The Patient Benefit Index for topical treatment (PBI-TOP): a new questionnaire to assess the treatment goals and preferences of people with psoriasisÂ
doi : 10.1093/bjd/ljae122
Deciding on the final set of questions and groups of questions in the Patient-Reported Impact of Dermatological Diseases (PRIDD) toolÂ
doi : 10.1093/bjd/ljae123
Targeting malignant melanoma cells expressing the protein CD20 enhances BRAF-targeted treatmentÂ
doi : 10.1093/bjd/ljae124
UK trends in work-related contact dermatitis caused by nickel, chromium and cobaltÂ
doi : 10.1093/bjd/ljae125
